The DOI matches its Crossref record; 26 of the 28 references it cites were found in a registry or an index.
Identification of the Nicotinic Receptor Subtypes Expressed on Dopaminergic Terminals in the Rat Striatum
Open accessAbstract
Neuronal nicotinic acetylcholine receptors (nAChRs) expressed on mesostriatal dopaminergic neurons are thought to mediate several behavioral effects of nicotine, including locomotion, habit learning, and reinforcement. Using immunoprecipitation and ligand-binding techniques, we have shown that both alpha6beta2* and alpha4(nonalpha6)beta2* nAChRs are expressed in the caudate-putamen and that only alpha6* nAChRs can bind alpha-conotoxin MII and methyllycaconitine with affinities of 1.3 and 40 nm, respectively. Further studies performed on 6-hydroxydopamine-lesioned striatum led to the identification of nAChR subtypes selectively expressed on dopaminergic terminals [alpha4alpha5beta2, alpha4alpha6beta2(beta3), and alpha6beta2(beta3)], nondopaminergic neuronal structures (alpha2alpha4beta2), or both structures (alpha4beta2). The identification of the nAChRs expressed on striatal dopaminergic terminals opens up the possibility of developing selective nAChR ligands active on dopaminergic systems and associated diseases, such as Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DA neurons express heteromeric nAChRs containing the α4, α5, α6, β2, and β3 subunits in various combinations, with the predominant subtypes being α4/β2/α5 and α4/α6/ β2/β3.”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Zoli et al. 2002
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LIGAND: A versatile computerized approach for characterization of ligand-binding systems
Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,373
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Self-citationNicotinic Receptors at the Amino Acid Level
Corringer, P., Novère, N. G. L., & Changeux, J. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.431 · Cited by 832
Role of dopamine in the behavioural actions of nicotine related to addiction
Chiara, G. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00122-9 · Cited by 698
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674
Self-citationEndogenous nicotinic cholinergic activity regulates dopamine release in the striatum
Zhou, F.-M., Liang, Y., & Dani, J. A. (2001) · Nature Neuroscience · doi:10.1038/nn769 · Cited by 585
A New α-Conotoxin Which Targets α3β2 Nicotinic Acetylcholine Receptors
Cartier, G. E., Yoshikami, D., Gray, W. R., Luo, S., Olivera, B. M., & McIntosh, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7522 · Cited by 489
Self-citationNovère, N. L., & Changeux, J. (1995) · Journal of Molecular Evolution · doi:10.1007/bf00167110 · Cited by 429
Identification of four classes of brain nicotinic receptors using beta2 mutant mice.
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · PubMed Central · doi:10.1523/jneurosci.18-12-04461.1996 · Cited by 387
Self-citationLe Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385
Self-citation
Research works printed but not linked: 1
- Lindstrom J (2000) The structure of nAChRs. In: Neuronal nicotinic receptors, Handbook of experimental pharmacology, Vol 144 (Cle- menti F, Fornasari D, and Gotti C, eds), pp 101-162. Berlin: Springer.
Cited by
Sorted by citations
ConusVenoms: A Rich Source of Novel Ion Channel-Targeted Peptides
Terlau, H., & Olivera, B. M. (2004) · Physiological Reviews · doi:10.1152/physrev.00020.2003 · Cited by 898
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
Self-citationNeuronal nicotinic receptors: from structure to pathology
Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970
Self-citationVariants in Nicotinic Receptors and Risk for Nicotine Dependence
Bierut, L. J., Stitzel, J. A., Wang, J. C., Hinrichs, A. L., Grucza, R. A., Xuei, X., Saccone, N. L., Saccone, S. F., Bertelsen, S., Fox, L., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111711 · Cited by 648
Nicotinic acetylcholine receptors and the regulation of neuronal signalling
Dajas‐Bailador, F., & Wonnacott, S. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.04.006 · Cited by 618
The dynamic effects of nicotine on the developing brain
Dwyer, J. B., McQuown, S. C., & Leslie, F. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.003 · Cited by 559
Champtiaux, N., Gotti, C., Cordero‐Erausquin, M., David, D. J. P., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F., Novère, N. G. L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 512
Self-citationStructural and functional diversity of native brain neuronal nicotinic receptors
Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469
Self-citationSalminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1526 · Cited by 401
Self-citationDiversity of vertebrate nicotinic acetylcholine receptors
Millar, N. S., & Gotti, C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.041 · Cited by 441
Self-citationStriatal dopamine neurotransmission: Regulation of release and uptake
Sulzer, D., Cragg, S. J., & Rice, M. E. (2016) · Basal Ganglia · doi:10.1016/j.baga.2016.02.001 · Cited by 382
Calabresi, P., Picconi, B., Parnetti, L., & Filippo, M. D. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70600-7 · Cited by 343
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease
Huot, P., Johnston, T. H., Koprich, J. B., Fox, S. H., & Brotchie, J. M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005678 · Cited by 335
Smoking, nicotine and Parkinson's disease
Quik, M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.008 · Cited by 330
Dopamine release in the basal ganglia
Rice, M. E., Patel, J. C., & Cragg, S. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.066 · Cited by 295
Heterogeneity and complexity of native brain nicotinic receptors
Gotti, C., Moretti, M., Gaimarri, A., Zanardi, A., Clementi, F., & Zoli, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.023 · Cited by 282
Self-citationNicotine: from molecular mechanisms to behaviour
Wonnacott, S., Sidhpura, N., & Balfour, D. J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.12.002 · Cited by 263
Nicotine as a modulator of behavior: beyond the inverted U
Picciotto, M. R. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00230-x · Cited by 257
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252
Self-citationExley, R. A., & Cragg, S. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707510 · Cited by 271
Meaningful silences: how dopamine listens to the ACh pause
Cragg, S. J. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.003 · Cited by 245
Exley, R., Clements, M. A., Hartung, H., McIntosh, J. M., & Cragg, S. J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301617 · Cited by 242
Self-citationNicotinic acetylcholine receptor-mediated calcium signaling in the nervous system
Shen, J., & Yakel, J. L. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.64 · Cited by 242
Gotti, C., Guiducci, S., Tedesco, V., Corbioli, S., Zanetti, L., Moretti, M., Zanardi, A., Rimondini, R., Mugnaini, M., Clementi, F., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5095-09.2010 · Cited by 226
Self-citationGrady, S. R., Moretti, M., Zoli, M., Marks, M. J., Zanardi, A., Pucci, L., Clementi, F., & Gotti, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5121-08.2009 · Cited by 222
Self-citationCui, C., Booker, T. K., Allen, R. S., Grady, S. R., Whiteaker, P., Marks, M. J., Salminen, O., Tritto, T., Butt, C. M., Allen, W. R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11045.2003 · Cited by 213
Self-citationPicciotto, M. R. (2007) · Frontiers in bioscience · doi:10.2741/2695 · Cited by 212
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104047273 · Cited by 203
Drenan, R. M., Grady, S. R., Whiteaker, P., McClure-Begley, T., McKinney, S., Miwa, J. M., Bupp, S., Heintz, N., McIntosh, J. M., Bencherif, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.09.009 · Cited by 197
Self-citationMoser, N., Mechawar, N., Jones, I., Gochberg-Sarver, A., Orr-Urtreger, A., Plomann, M., Salas, R., Molles, B., Marubio, L., Roth, U., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04498.x · Cited by 214
Dopamine Signaling in Dorsal Versus Ventral Striatum: The Dynamic Role of Cholinergic Interneurons
Threlfell, S., & Cragg, S. J. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00011 · Cited by 200
α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease
Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 201
Analogs of α-Conotoxin MII Are Selective for α6-Containing Nicotinic Acetylcholine Receptors
McIntosh, J. M., Azam, L., Staheli, S. T., Dowell, C. D., Lindstrom, J. M., Kuryatov, A., Garrett, J. E., Marks, M. J., & Whiteaker, P. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.944 · Cited by 194
Self-citationCurrent pharmacological treatments for nicotine dependence
George, T. P., & O’Malley, S. S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.11.003 · Cited by 179
Molecular Mechanisms Underlying Behaviors Related to Nicotine AddictionPreprint
Picciotto, M. R., & Kenny, P. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012112 · Cited by 186
A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction
Hong, L. E., Hodgkinson, C. A., Yang, Y., Sampath, H., Ross, T. J., Buchholz, B., Salmeron, B. J., Srivastava, V., Thaker, G. K., Goldman, D. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004745107 · Cited by 169
Gonzales, K. K., & Smith, Y. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12762 · Cited by 175
DARPP-32 mediates the actions of multiple drugs of abuse
Svenningsson, P., Nairn, A. C., & Greengard, P. (2005) · The AAPS Journal · doi:10.1208/aapsj070235 · Cited by 174
Nicotine Gateway Effects on Adolescent Substance Use
Ren, M., & Lotfipour, S. (2019) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2019.7.41661 · Cited by 166
Mechanisms of Nicotine Addiction
Picciotto, M. R., & Kenny, P. J. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039610 · Cited by 161
Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia
Jaunarajs, K. L. E., Bonsi, P., Chesselet, M.-F., Standaert, D. G., & Pisani, A. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.02.002 · Cited by 158
Jackson, K. J., Marks, M. J., Vann, R. E., Chen, X., Gamage, T. F., Warner, J. A., & Damaj, M. I. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.165738 · Cited by 156
Nicotine and Parkinson's disease: implications for therapy
Quik, M., O'Leary, K., & Tanner, C. M. (2008) · Movement Disorders · doi:10.1002/mds.21900 · Cited by 154
α-Conotoxin PIA Is Selective for α6 Subunit-Containing Nicotinic Acetylcholine Receptors
Dowell, C., Olivera, B. M., Garrett, J. E., Staheli, S. T., Watkins, M., Kuryatov, A., Yoshikami, D., Lindstrom, J. M., & McIntosh, J. M. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08445.2003 · Cited by 161
Self-citationAssembly and trafficking of nicotinic acetylcholine receptors (Review)
Millar, N. S., & Harkness, P. C. (2008) · Molecular Membrane Biology · doi:10.1080/09687680802035675 · Cited by 143
Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons
Azam, L., Chen, Y., & Leslie, F. M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.011 · Cited by 138
The Role of α6-Containing Nicotinic Acetylcholine Receptors in Nicotine Reward and Withdrawal
Jackson, K. J., McIntosh, J. M., Brunzell, D. H., Sanjakdar, S. S., & Damaj, M. I. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155457 · Cited by 135
Self-citationCellular, Synaptic and Network Effects of Acetylcholine in the Neocortex
Colangelo, C., Shichkova, P., Keller, D. X., Markram, H., & Ramaswamy, S. (2019) · Frontiers in Neural Circuits · doi:10.3389/fncir.2019.00024 · Cited by 143
Gotti, C., Moretti, M., Clementi, F., Riganti, L., McIntosh, J. M., Collins, A. C., Marks, M. J., & Whiteaker, P. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011940 · Cited by 133
Self-citationFowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131
Mao, D., Perry, D. C., Yasuda, R. P., Wolfe, B. B., & Kellar, K. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05011.x · Cited by 133
Tuesta, L. M., Fowler, C. D., & Kenny, P. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.026 · Cited by 135
Doura, M. B., Gold, A. B., Keller, A. B., & Perry, D. C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.056 · Cited by 129
The A-superfamily of Conotoxins
Santos, A. D., McIntosh, J. M., Hillyard, D. R., Cruz, L. J., & Olivera, B. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309654200 · Cited by 129
Self-citationCholinergic modulation of striatal microcircuits
Abudukeyoumu, N., Hernández-Flores, T., Garcia-Munoz, M., & Arbuthnott, G. W. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13949 · Cited by 144
Striatal α6* Nicotinic Acetylcholine Receptors: Potential Targets for Parkinson’s Disease Therapy
Quik, M., & McIntosh, J. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094375 · Cited by 129
Self-citationGotti, C., Moretti, M., Bohr, I., Ziabreva, I., Vailati, S., Longhi, R., Riganti, L., Gaimarri, A., McKeith, I., Perry, R., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.005 · Cited by 137
Self-citationThe role of DARPP-32 in the actions of drugs of abuse
Nairn, A. C., Svenningsson, P., Nishi, A., Fisone, G., Girault, J., & Greengard, P. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.05.010 · Cited by 126
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 134
Behavioral and biochemical effects of neonicotinoid thiamethoxam on the cholinergic system in rats
Rodrigues, K. J. A., de Santana, M. B., do Nascimento, J. L. M., Picanço-Diniz, D. L. W., Maués, L. A. L., dos Santos, S. N., Ferreira, V. M. M., Alfonso, M., Durán, R., & Faro, L. R. F. (2009) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2009.04.021 · Cited by 125
Molecules and circuits involved in nicotine addiction: The many faces of smoking
Picciotto, M. R., & Mineur, Y. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.028 · Cited by 123
Convergent evidence for abnormal striatal synaptic plasticity in dystonia
Peterson, D. A., B, T. J. S. A., & Howard Poizner, A. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.003 · Cited by 120
Impairment of reward-related learning by cholinergic cell ablation in the striatum
Kitabatake, Y., Hikida, T., Watanabe, D., Pastan, I. H., & Nakanishi, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032899100 · Cited by 115
Pistillo, F., Clementi, F., Zoli, M., & Gotti, C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.10.002 · Cited by 120
Self-citationNicotinic receptors as CNS targets for Parkinson's disease.
Quik, M., Bordia, T., & O'Leary, K. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.015 · Cited by 119
Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR
Swan, G. E., Valdes, A. M., Ring, H. Z., Khroyan, T. V., Jack, L. M., Ton, C. C. T., Curry, S. J., & McAfee, T. A. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500281 · Cited by 115
Nicotinic Receptors Modulate Transmitter Cross Talk in the CNS: Nicotinic Modulation of Transmitters
Wonnacott, S., Barik, J., Dickinson, J., & Jones, I. W. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:30:1:137 · Cited by 110
Nicke, A., Wonnacott, S., & Lewis, R. J. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04145.x · Cited by 109
Molecular and Cellular Mechanisms of Action of Nicotine in the CNS
Barik, J., & Wonnacott, S. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_7 · Cited by 112
Perry, D. C., Mao, D., Gold, A. B., McIntosh, J. M., Pezzullo, J. C., & Kellar, K. J. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121228 · Cited by 106
Self-citationKramer, P. F., Brill-Weil, S. G., Cummins, A. C., Zhang, R., Camacho-Hernandez, G. A., Newman, A. H., Eldridge, M. A. G., Averbeck, B. B., & Khaliq, Z. M. (2022) · Neuron · doi:10.1016/j.neuron.2022.07.011 · Cited by 104
Improgo, M. R., Scofield, M. D., Tapper, A. R., & Gardner, P. D. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.05.003 · Cited by 108
Parker, S. L., Fu, Y., McAllen, K., Luo, J., McIntosh, J. M., Lindstrom, J. M., & Sharp, B. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.611 · Cited by 105
Self-citationDopamine and Acetylcholine, a Circuit Point of View in Parkinson’s Disease
Rizzi, G., & Tan, K. R. (2017) · Frontiers in Neural Circuits · doi:10.3389/fncir.2017.00110 · Cited by 109
Drenan, R. M., Nashmi, R., Imoukhuede, P., Just, H., McKinney, S., & Lester, H. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039180 · Cited by 100
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800403 · Cited by 100
Wing, V. C., Wass, C., Soh, D. W., & George, T. P. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06261.x · Cited by 99
Chatterjee, S., & Bartlett, S. E. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710790966597 · Cited by 100
Identification of Sequence Motifs That Target Neuronal Nicotinic Receptors to Dendrites and Axons
Xu, J., Zhu, Y., & Heinemann, S. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0840-06.2006 · Cited by 96
Lai, A., Parameswaran, N., Khwaja, M., Whiteaker, P., Lindstrom, J. M., Fan, H., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006429 · Cited by 112
Self-citationBordia, T., Grady, S., McIntosh, J. M., & Quik, M. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035998 · Cited by 104
Self-citationHsu, Y. A., Tempest, L., Quina, L. A., Wei, A. D., Zeng, H., & Turner, E. E. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2927-13.2013 · Cited by 95
CNS Localization of Neuronal Nicotinic Receptors
Nashmi, R., & Lester, H. A. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:30:1:181 · Cited by 97
Quik, M., Perez, X. A., & Grady, S. R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.001 · Cited by 97
The Genetic Components of Alcohol and Nicotine Co-Addiction: From Genes to Behavior
Schlaepfer, I. R., Hoft, N. R., & Ehringer, M. A. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801020124 · Cited by 96
Sarginson, J. E., Killen, J. D., Lazzeroni, L. C., Fortmann, S. P., Ryan, H. S., Schatzberg, A. F., & Murphy, G. M. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31155 · Cited by 93
Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research
Damar, U., Gersner, R., Johnstone, J. T., Schachter, S. C., & Rotenberg, A. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1175303 · Cited by 93
Nicotinic acetylcholine receptors in neurological and psychiatric diseases
Terry, A. V., Jones, K., & Bertrand, D. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106764 · Cited by 90
Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric Subtypes
Turner, J. R., & Kellar, K. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2112-05.2005 · Cited by 89
Moretti, M., Vailati, S., Zoli, M., Lippi, G., Riganti, L., Longhi, R., Viegi, A., Clementi, F., & Gotti, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.85 · Cited by 89
Self-citationUp-regulation of Nicotinic Receptors by Nicotine Varies with Receptor Subtype
Walsh, H., Govind, A. P., Mastro, R., Hoda, J. C., Bertrand, D., Vallejo, Y., & Green, W. N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m703432200 · Cited by 87
The subcortical and neurochemical organization of the ventral and dorsal attention networks
Alves, P. N., Forkel, S. J., Corbetta, M., & de Schotten, M. T. (2022) · Communications Biology · doi:10.1038/s42003-022-04281-0 · Cited by 89
Quik, M., Vailati, S., Bordia, T., Kulak, J. M., Fan, H., McIntosh, J. M., Clementi, F., & Gotti, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.006015 · Cited by 86
Self-citationThe Duplicated α7 Subunits Assemble and Form Functional Nicotinic Receptors with the Full-length α7
Wang, Y., Xiao, C., Indersmitten, T., Freedman, R., Leonard, S. S., & Lester, H. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.582858 · Cited by 86
Quik, M., Sum, J., Whiteaker, P., McCallum, S. E., Marks, M. J., Musachio, J. L., McIntosh, J. M., Collins, A. C., & Grady, S. R. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1169 · Cited by 86
Self-citationPapke, R. L., Dwoskin, L. P., & Crooks, P. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04355.x · Cited by 83
Free radical production induced by methamphetamine in rat striatal synaptosomes
Pubill, D., Chipana, C., Camins, A., Pallàs, M., Camarasa, J., & Escubedo, E. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.08.008 · Cited by 80
Nicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81
Heterogeneity of Nicotinic Cholinergic Receptors in Rat Superior Cervical and Nodose Ganglia
Mao, D., Yasuda, R. P., Fan, H., Wolfe, B. B., & Kellar, K. J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027458 · Cited by 81
Janhunen, S. K., & Ahtee, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.09.008 · Cited by 83
Metadata
- Authors
- Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C.
- Affiliations
- University of Milan (IT)
- University of Modena and Reggio Emilia (IT)
- University of Utah (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2002-10-15
- Volume
- 22
- Issue
- 20
- Pages
- 8785-8789
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6757689
- OpenAlex
- W2162000418
- Cited by
- 407
- References
- 28
- Citations by year
- 2026: 3 · 2025: 12 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 11 · 2020: 10 · 2019: 13 · 2018: 15 · 2017: 9 · 2016: 16 · 2015: 13 · 2014: 16 · 2013: 10 · 2012: 14
- FWCI
- 8.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute of Mental Health (MH53631, R01MH053631, R29MH053631)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, dopaminergic terminals, striatum, caudate-putamen, alpha4beta2 nAChR, alpha-conotoxin MII, methyllycaconitine, nicotine, 6-hydroxydopamine lesion, Parkinson's disease
- MeSH terms
- Animals, Binding, Competitive, Corpus Striatum, Dopamine, Ligands, Male, Precipitin Tests, Receptors, Nicotinic, Specific Pathogen-Free Organisms, Oxidopamine, Rats, Sprague-Dawley, Presynaptic Terminals, Nicotinic Agonists, Nicotinic Antagonists, Dopamine Uptake Inhibitors, Protein Subunits, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review